Abstract
Stem cell-based therapy has shown exciting efficacy in pre-clinical studies on different neurodegenerative diseases (NDs). However, no clinically applicable stem-cell-derived neurons are available to the patients with NDs. There exist some obstacles associated with stem cell therapy, which need to be overcome in future clinical studies. In this chapter, more challenges and new strategies will be explored to accelerate the clinical translation of a human embryonic stem cell (hESC)/induced pluripotent stem cell (iPSC)-derived neural cell product to patients with NDs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
D.G. Abernathy, W.K. Kim, M.J. McCoy, A.M. Lake, R. Ouwenga, S.W. Lee, X. Xing, D. Li, H.J. Lee, R.O. Heuckeroth, et al., MicroRNAs induce a permissive chromatin environment that enables neuronal subtype-specific reprogramming of adult human fibroblasts. Cell Stem Cell 21(332–348), e339 (2017)
H. Araki, F. Miura, A. Watanabe, C. Morinaga, F. Kitaoka, Y. Kitano, N. Sakai, Y. Shibata, M. Terada, S. Goto, S. Yamanaka, M. Takahashi, T. Ito, Base-resolution methylome of retinal pigment epithelial cells used in the first trial of human induced pluripotent stem cell-based autologous transplantation. Stem Cell Rep. 13(4), 761–774 (2019)
B.J. Berry, A.S.T. Smith, J.E. Young, D.L. Mack, Advances and current challenges associated with the use of human induced pluripotent stem cells in modeling neurodegenerative disease. Cells Tissues Organs 205(5-6), 1–19 (2018)
S.S. Choi, S.R. Lee, S.U. Kim, H.J. Lee, Alzheimer’s disease and stem cell therapy. Exp. Neurobiol. 23, 45–52 (2014)
T. Duncan, M. Valenzuela, Alzheimer’s disease, dementia, and stem cell therapy. Stem Cell Res. Ther. 8, 111 (2017)
P.J. Hallett, M. Deleidi, A. Astradsson, G.A. Smith, O. Cooper, T.M. Osborn, M. Sundberg, M.A. Moore, E. Perez-Torres, A.L. Brownell, et al., Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson’s disease. Cell Stem Cell 16, 269–274 (2015)
D.W. Han, N. Tapia, A. Hermann, K. Hemmer, S. Hoing, M.J. Arauzo-Bravo, H. Zaehres, G. Wu, S. Frank, S. Moritz, et al., Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 10, 465–472 (2012)
H. Huang, L. Chen, G. Mao, H.S. Sharma, Clinical neurorestorative cell therapies: developmental process, current state and future prospective. J. Neurorestoratol. 8(2), 61–82 (2020)
H. Jiang, R. Wang, Z. Zheng, J. Zhu, Deep brain stimulation for the treatment of cerebral palsy: a review. Brain Sci. Adv 6(1), 20–29 (2020)
Z. Leng, N. Kethidi, A.J. Chang, L. Sun, J. Zhai, Y. Yang, J. Xu, X. He, Muse cells and neurorestoratology. J. Neurorestoratol. 7(1), 18–25 (2019)
M.S. Lim, M.Y. Chang, S.M. Kim, S.H. Yi, H. Suh-Kim, S.J. Jung, M.J. Kim, J.H. Kim, Y.S. Lee, S.Y. Lee, et al., Generation of dopamine neurons from rodent fibroblasts through the expandable neural precursor cell stage. J. Biol. Chem. 290, 17401–17414 (2015)
O. Lindvall, R.A. Barker, O. Brüstle, O. Isacson, C.N. Svendsen, Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell 10(2), 151–155 (2012)
E. Lujan, S. Chanda, H. Ahlenius, T.C. Sudhof, M. Wernig, Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc. Natl. Acad. Sci. U. S. A. 109, 2527–2532 (2012)
M. Mandai, A. Watanabe, Y. Kurimoto, Y. Hirami, C. Morinaga, T. Daimon, M. Fujihara, H. Akimaru, N. Sakai, Y. Shibata, M. Terada, Y. Nomiya, S. Tanishima, M. Nakamura, H. Kamao, S. Sugita, A. Onishi, T. Ito, K. Fujita, S. Kawamata, M.J. Go, C. Shinohara, K.-I. Hata, M. Sawada, M. Yamamoto, S. Ohta, Y. Ohara, K. Yoshida, J. Kuwahara, Y. Kitano, N. Amano, M. Umekage, F. Kitaoka, A. Tanaka, C. Okada, N. Takasu, S. Ogawa, S. Yamanaka, M. Takahashi, Autologous induced stem-cell-derived retinal cells for macular degeneration. N. Engl. J. Med. 376(11), 1038–1046 (2017)
C. Maucksch, K.S. Jones, B. Connor, Concise review: The involvement of SOX2 in direct reprogramming of induced neural stem/precursor cells. Stem Cells Transl. Med. 2, 579–583 (2013)
L. Mazzini, D. Ferrari, P.R. Andjus, L. Buzanska, R. Cantello, F. De Marchi, M. Gelati, R. Giniatullin, J.C. Glover, M. Grilli, et al., Advances in stem cell therapy for amyotrophic lateral sclerosis. Expert. Opin. Biol. Ther. 18, 865–881 (2018)
R. Playne, K. Jones, B. Connor, Generation of dopamine neuronal-like cells from induced neural precursors derived from adult human cells by non-viral expression of lineage factors. J. Stem Cells Regen. Med. 14, 34–44 (2018)
N.J. Scolding, M. Pasquini, S.C. Reingold, J.A. Cohen, Cell-based therapeutic strategies for multiple sclerosis. Brain 140, 2776–2796 (2017)
I. Velasco, P. Salazar, A. Giorgetti, V. Ramos-Mejia, J. Castano, D. Romero-Moya, P. Menendez, Concise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion. Stem Cells 32, 2811–2817 (2014)
Q. Zhou, P. Tripathi, How to remake a fibroblast into a neural stem cell. Cell Stem Cell 10, 347–348 (2012)
Acknowledgement
This work was supported by National Natural Science Foundation of China (NSFC 81571241), Department of Science and Technology of Shandong Province, China (2017GSF18104), and Basic Research Fund from Natural Science Foundation of Shandong Province, China (ZR2019ZD39), Merit Review Award Number I01 RX002264-01A2 from the United States (U.S.), and Department of Veterans Affairs Rehabilitation Research and Development (RR&D) Service and NIH (R21 NS103074-01).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Han, F., Lu, P. (2020). Future Challenges and Perspectives for Stem Cell Therapy of Neurodegenerative Diseases. In: Han, F., Lu, P.(. (eds) Stem Cell-based Therapy for Neurodegenerative Diseases. Advances in Experimental Medicine and Biology, vol 1266. Springer, Singapore. https://doi.org/10.1007/978-981-15-4370-8_10
Download citation
DOI: https://doi.org/10.1007/978-981-15-4370-8_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4369-2
Online ISBN: 978-981-15-4370-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)